Cellinta
London
About Cellinta
Cellinta creates a platform for locating regulatory circuits specific to cancer stem cells. These can be used in gene therapies to selectively deliver anti-cancer payloads and obstruct several pathways required for tumor growth and immune stimulation at the same time.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Sep 2020)
- Website: cellinta.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cellinta-2727032 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.